Abstract
Twenty-two cases of primary gastric lymphoma have been clinicopathologically reviewed and factors influences the prognosis were examined. An increased tumor size of more than 10 cm, an increased tumoral penetration, a lymph node involvement, and stage IV classification decreased the survival rates. All patients given stage I classification have remained alive without having received chemotherapy. The survivors of stages III & IV amounted to only three patients who were treated by surgery and systemic chemotherapy. A radical operation is the choice of treatment for a gastric lymphoma but aggressive chemotherapy should be supplemented for advanced cases.
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Female
-
Humans
-
Lymphatic Metastasis
-
Lymphoma / drug therapy
-
Lymphoma / pathology
-
Lymphoma / therapy*
-
Male
-
Mercaptopurine / administration & dosage
-
Middle Aged
-
Neoplasm Invasiveness
-
Prednisone / administration & dosage
-
Procarbazine / administration & dosage
-
Prognosis
-
Stomach Neoplasms / drug therapy
-
Stomach Neoplasms / pathology
-
Stomach Neoplasms / therapy*
-
Vincristine / administration & dosage
Substances
-
Procarbazine
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Mercaptopurine
-
Prednisone
Supplementary concepts
-
CHOP protocol
-
COPP protocol